CALUMET INC: UBS INCREASES TARGET PRICE TO $26, UP FROM $13.25
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Should l Buy CLMT?
Source: moomoo
- Price Increase Announcement: Calumet has raised its target price for its stock to $26 from a previous price of $13.25.
- Market Impact: This significant increase reflects positive expectations for the company's performance and potential growth in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLMT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLMT
Wall Street analysts forecast CLMT stock price to fall
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 25.980
Low
19.00
Averages
23.67
High
28.00
Current: 25.980
Low
19.00
Averages
23.67
High
28.00
About CLMT
Calumet, Inc. manufactures, formulates and markets a diversified slate of specialty branded products and renewable fuels to customers across a range of consumer-facing and industrial markets. Its segments include Specialty Products and Solutions; Performance Brands; Montana/Renewables, and Corporate. Specialty Products and Solutions segment manufactures and markets a variety of solvents, waxes, customized lubricating oils, white oils, petrolatum, gels, esters, and other products. Performance Brands segment blend, package and market high performance products through its Royal Purple, Bel-Ray, and TruFuel brands. Montana/Renewables segment comprises two facilities: renewable fuels and specialty asphalt. At its Montana Renewables facility, it processes a variety of geographically advantaged renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha that are distributed into renewables markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CALUMET INC: UBS INCREASES TARGET PRICE TO $26, UP FROM $13.25
- Price Increase Announcement: Calumet has raised its target price for its stock to $26 from a previous price of $13.25.
- Market Impact: This significant increase reflects positive expectations for the company's performance and potential growth in the market.
See More
Calumet to Report Q4 and FY 2025 Results on February 27, 2026
- Earnings Report Announcement: Calumet, Inc. plans to release its Fourth Quarter and Fiscal Year 2025 results on February 27, 2026, which is expected to provide critical financial data for assessing company performance.
- Conference Call Schedule: The company will hold a conference call at 9:00 AM ET on February 27 to discuss financial and operational results, allowing investors and analysts to participate via a live webcast.
- Participation Details: Interested participants can pre-register through the provided link and dial into the conference call using the toll-free number to ensure smooth access to the discussion.
- Replay Availability: A replay of the conference call will be available a few hours after the event on the investor relations section of the company's website, allowing investors who could not attend live to access the information.
See More
Calumet to Report Q4 and FY 2025 Results on February 27, 2026
- Earnings Announcement: Calumet, Inc. plans to report its Fourth Quarter and Fiscal Year 2025 results on February 27, 2026, which is expected to provide investors with critical financial and operational insights to assess the company's performance.
- Conference Call Schedule: The company will hold a conference call at 9:00 AM ET on February 27, allowing investors and analysts to participate via a live webcast, enhancing transparency and fostering engagement with stakeholders.
- Participation Details: Interested parties can pre-register through the provided link and join the call by dialing the toll-free number 1-844-695-5524 for US participants or 1-412-317-0700 for international callers, ensuring smooth participation in the discussion.
- Replay Availability: A replay of the conference call will be accessible a few hours after the event on the investor relations section of the company's website, facilitating information access for investors who could not attend live, thereby improving overall information transparency.
See More
Calumet to Report Q4 and FY 2025 Earnings on February 27, 2026
- Earnings Release Schedule: Calumet, Inc. plans to report its Fourth Quarter and Fiscal Year 2025 results on February 27, 2026, which is expected to provide investors with crucial financial and operational data to assess the company's performance and future outlook.
- Conference Call Details: The company will hold a conference call at 9:00 AM ET on February 27 to discuss the financial results, allowing investors and analysts to participate via a live webcast, enhancing transparency and interactivity.
- Participation Instructions: Interested participants can pre-register through the provided link and dial in at 1-844-695-5524 (US) or 1-412-317-0700 (International) to ensure smooth access to the call, facilitating broader engagement with stakeholders.
- Replay Availability: A replay of the conference call will be available a few hours after the event on the investor relations section of the company's website, allowing those unable to attend live to access key information and improve information accessibility.
See More
Calumet Inc. Extends Loan Maturity to 2031
- Loan Maturity Extension: Calumet Inc. has extended the maturity date of its existing asset-based loan from January 2027 to January 2031, ensuring financial flexibility for the next five years, which helps the company maintain stability amid market fluctuations.
- Optimized Financing Size: The amended loan facility provides total commitments of $500 million, subject to borrowing base limitations, offering the company greater capital utilization space to support its business development and investment plans.
- Enhanced Bank Support: The loan is led by Bank of America, expanding Calumet's bank group, which reflects financial institutions' confidence in the company's future growth and further solidifies its financing foundation.
- Impact of Business Restructuring: Following the divestiture of the industrial portion of its Royal Purple® business, Calumet has optimized its borrowing base capacity, enhancing its overall debt maturity profile to improve survival and growth potential in a competitive market.
See More
Calumet Inc. Closes $405 Million Senior Notes Offering
- Successful Private Placement: Calumet, Inc. has closed a $405 million offering of 9.75% Senior Notes, issued at 98.996% of par, resulting in net proceeds of approximately $393 million, significantly enhancing the company's liquidity and financial flexibility.
- Upsized Offering: The offering was increased from an initial size of $350 million to $405 million, reflecting strong market confidence in Calumet, which is expected to provide robust funding support for future business development.
- Debt Redemption Plan: Calumet plans to use the net proceeds and cash on hand to redeem its outstanding 11.00% and 8.125% Senior Notes due in 2026 and 2027, respectively, which is anticipated to alleviate debt pressure and optimize the capital structure.
- Operational Improvements Driving Success: CEO Todd Borgmann noted that over $220 million in debt reduction and operational cost savings in 2025 laid the groundwork for this oversubscribed offering, with future value creation expected through stable cash flows and the MaxSAF™ 150 expansion project.
See More
CALUMET INC: UBS INCREASES TARGET PRICE TO $26, UP FROM $13.25
- Price Increase Announcement: Calumet has raised its target price for its stock to $26 from a previous price of $13.25.
- Market Impact: This significant increase reflects positive expectations for the company's performance and potential growth in the market.
See More
Calumet to Report Q4 and FY 2025 Results on February 27, 2026
- Earnings Report Announcement: Calumet, Inc. plans to release its Fourth Quarter and Fiscal Year 2025 results on February 27, 2026, which is expected to provide critical financial data for assessing company performance.
- Conference Call Schedule: The company will hold a conference call at 9:00 AM ET on February 27 to discuss financial and operational results, allowing investors and analysts to participate via a live webcast.
- Participation Details: Interested participants can pre-register through the provided link and dial into the conference call using the toll-free number to ensure smooth access to the discussion.
- Replay Availability: A replay of the conference call will be available a few hours after the event on the investor relations section of the company's website, allowing investors who could not attend live to access the information.
See More
Calumet to Report Q4 and FY 2025 Results on February 27, 2026
- Earnings Announcement: Calumet, Inc. plans to report its Fourth Quarter and Fiscal Year 2025 results on February 27, 2026, which is expected to provide investors with critical financial and operational insights to assess the company's performance.
- Conference Call Schedule: The company will hold a conference call at 9:00 AM ET on February 27, allowing investors and analysts to participate via a live webcast, enhancing transparency and fostering engagement with stakeholders.
- Participation Details: Interested parties can pre-register through the provided link and join the call by dialing the toll-free number 1-844-695-5524 for US participants or 1-412-317-0700 for international callers, ensuring smooth participation in the discussion.
- Replay Availability: A replay of the conference call will be accessible a few hours after the event on the investor relations section of the company's website, facilitating information access for investors who could not attend live, thereby improving overall information transparency.
See More
Calumet to Report Q4 and FY 2025 Earnings on February 27, 2026
- Earnings Release Schedule: Calumet, Inc. plans to report its Fourth Quarter and Fiscal Year 2025 results on February 27, 2026, which is expected to provide investors with crucial financial and operational data to assess the company's performance and future outlook.
- Conference Call Details: The company will hold a conference call at 9:00 AM ET on February 27 to discuss the financial results, allowing investors and analysts to participate via a live webcast, enhancing transparency and interactivity.
- Participation Instructions: Interested participants can pre-register through the provided link and dial in at 1-844-695-5524 (US) or 1-412-317-0700 (International) to ensure smooth access to the call, facilitating broader engagement with stakeholders.
- Replay Availability: A replay of the conference call will be available a few hours after the event on the investor relations section of the company's website, allowing those unable to attend live to access key information and improve information accessibility.
See More
Calumet Inc. Extends Loan Maturity to 2031
- Loan Maturity Extension: Calumet Inc. has extended the maturity date of its existing asset-based loan from January 2027 to January 2031, ensuring financial flexibility for the next five years, which helps the company maintain stability amid market fluctuations.
- Optimized Financing Size: The amended loan facility provides total commitments of $500 million, subject to borrowing base limitations, offering the company greater capital utilization space to support its business development and investment plans.
- Enhanced Bank Support: The loan is led by Bank of America, expanding Calumet's bank group, which reflects financial institutions' confidence in the company's future growth and further solidifies its financing foundation.
- Impact of Business Restructuring: Following the divestiture of the industrial portion of its Royal Purple® business, Calumet has optimized its borrowing base capacity, enhancing its overall debt maturity profile to improve survival and growth potential in a competitive market.
See More
Calumet Inc. Closes $405 Million Senior Notes Offering
- Successful Private Placement: Calumet, Inc. has closed a $405 million offering of 9.75% Senior Notes, issued at 98.996% of par, resulting in net proceeds of approximately $393 million, significantly enhancing the company's liquidity and financial flexibility.
- Upsized Offering: The offering was increased from an initial size of $350 million to $405 million, reflecting strong market confidence in Calumet, which is expected to provide robust funding support for future business development.
- Debt Redemption Plan: Calumet plans to use the net proceeds and cash on hand to redeem its outstanding 11.00% and 8.125% Senior Notes due in 2026 and 2027, respectively, which is anticipated to alleviate debt pressure and optimize the capital structure.
- Operational Improvements Driving Success: CEO Todd Borgmann noted that over $220 million in debt reduction and operational cost savings in 2025 laid the groundwork for this oversubscribed offering, with future value creation expected through stable cash flows and the MaxSAF™ 150 expansion project.
See More
